3-Substituted isocoumarins were prepared in a short and efficient way from 2-iodobenzoic acid and terminal alkynes in a one-pot Sonogashira reaction. Catalytic hydrogenation gave the corresponding dihydroisocoumarins. The cytotoxic activities of the resulting compounds against human leukaemia cell line (HL 60) were determined in a MTT assay, and structure-activity relationships are discussed.
Introduction
Isocoumarins are a large and structurally diverse class of bioactive natural products with widespread occurance in living organisms [1] , and considerable work has been published over decades about their chemistry [2] and biology [3] . A considerable number of natural and synthetic isocoumarins showed significant cytotoxic and antitumor activity. Among those are dihydroisocoumarins like AI-77-B (A), as well as numerous isocoumarins bearing substituents at C-3 ( Fig. 1) . The dihydroisocoumarin AI-77-B (A) shows in vitro cytotoxicity against human malignant A375-S2 and human cervical cancer HeLa cells [4] . The paraphaeosphaerins (B) recently isolated from cultures of Paraphaeosphaeria quadriseptana [5] are biogenetically related to the cytotoxic plant metabolites monocillin I and radicicol. NM-3 (C) is a synthetic analog of cytogenin (E), and potentiates antineoplastic effects of other chemotherapeutic agents and inhibits angiogenesis [6] . This compound is in phase I clinical trials. The isocoumarin 185322 (D) [7] , an analog of NM-3, is an inhibitor of microtubule assembly, and induces mitotic arrest and apoptosis of multiple myeloma cells.
The biological activities of the abovementioned and other isocoumarins and dihydroisocoumarins [8, 9] make this class of compounds interesting leads for development of new anticancer drugs. The most prominent structural features found in the bioactive com-0932-0776 / 09 / 0300-0313 $ 06.00 c 2009 Verlag der Zeitschrift für Naturforschung, Tübingen · http://znaturforsch.com pounds are oxygen substituents (mainly at C-8 and to a lesser extent at C-6), and side chains at C-3.
Since there is a large structural diversity in these side chains (length, branching, polarity, additional functional groups), we intended to get more insight into the influence of the C-3 substituents on cytotoxic activity. For this purpose a series of isocoumarins and dihydroisocoumarins with different substituents at C-3 was to be synthesized and screened for cytotoxic activity.
In addition to the classical synthetic approaches to the isocoumarin ring system starting from homophthalic acid and related compounds [2, 3] , organometallic methods have been introduced a few decades ago [10, 11] . In 1993, Kundu tion of phthalides [12] . In these reactions isocoumarins were obtained as minor by-products. Later on Liao and Cheng described an efficient method for the synthesis of isocoumarins from 2-iodobenzoic acid and terminal alkynes using Pd(PPh 3 ) 4 or Pd(PPh 3 ) 2 Cl 2 , ZnCl 2 and Et 3 N as catalysts [13] . We adopted this method for the preparation of our target compounds. In a recent publication it has been shown that the Pd-phosphine complexes can be replaced by Pd on charcoal [14] .
Results

2-
Iodobenzoic acid (1a) was used for Sonogashiratype reactions under catalysis of Pd(PPh 3 ) 2 Cl 2 and ZnCl 2 with five terminal alkynes to give directly, due to an intramolecular addition of the carboxylate to the alkyne, the isocoumarins 2a -e in 41 to 95 % yield (Scheme 1). In an alternative approach, carboxylic acid 1a was replaced by 2-iodobenzoyl chloride 1b and reacted with 5-methylhex-1-yne under otherwise unchanged conditions. Once again the isocoumarin 2c was formed, albeit in lower yield (64 % compared to 99 %).
In a further variant (Scheme 2), inspired by a report of Villemin and Goussu [15] and an accidental formation of an isocoumarin from an alkynyl ben- zoic ester in our hands [16] , we prepared the alkyne 5 by Sonogashira reaction of methyl 2-iodobenzoate (1c) with 5-methylhex-1-yne under catalysis of CuI and Pd(PPh 3 ) 2 Cl 2 . Upon treatment with methanolic KOH the isocoumarin 2c was obtained in very low yield (6 %). Thus the first variant starting from the carboxylic acid 1a was found to give the highest yield, and was exclusively used for the syntheses of the other isocoumarins.
The isocoumarins 2a -d were hydrogenated under Pd/C catalysis to give the dihydroisocoumarins 3a -d (Scheme 1) [17] .
An attempt to liberate the primary amino group protected as the N-alkylphthalimide in 2e by hydrazinolysis did not give the expected aminobutyl isocoumarin, but led to the known 1,2,3,4-tetrahydro-pyrido[1,2-b] isoquinolin-6-one (4) (Scheme 1) [18, 19] .
The antibacterial and antimycotic activities of the new compounds were determined in an agar diffusion assay against the bacteria Escherichia coli, Staphylococcus equorum, Pseudomonas antimicrobia, and Streptococcus entericus, and the fungi Aspergillus niger, Candida glabrata, Hypopichii burtonii, and Yarrowia lipolytica. The compounds did not show significant activities compared to the references tetracycline and clotrimazol (data not shown) [20] .
Finally, the cytotoxicity of the compounds was determined in a MTT assay on a human leukaemia cell line (HL 60) with cisplatin as a reference [21] . The results are shown in Table 1 .
Seven of these compounds showed moderate cytotoxicity with IC 50 values in the range of 40 -80 µ M. We could detect no significant differences in the cy- totoxic potencies of the isocoumarins and the corresponding dihydroisocoumarins.
The extremely poor activities of isocoumarin 2d and dihydroisocoumarin 3d might be explained by the correlation between cytotoxicity and log P values. The log P values of the compounds were determined by a HPLC method by comparison with known log P values of diphenyl ether, cinnamic acid, aniline and naphthaline [22] , and are shown in Table 2 . The inactive compounds 2d and 3d have very low log P values.
Discussion
Five new 3-substituted isocoumarins and four new dihydroisocoumarins were prepared in a convenient one-pot synthesis, and most of them showed very moderate cytotoxic activities, with the isocoumarins and the corresponding dihydro derivatives exhibiting almost equal potency. The differences in cytotoxic activity might be explained on the basis of log P values. Since none of the compounds prepared here has cytotoxic activity comparable to the drug candidates NM-3 and 185322, substitution (hydroxy and methoxy groups) at the benzoid ring of the isocoumarins seems to be more crucial than the nature of the substituents at C-3.
Experimental Section
Elemental analysis: Heraeus CHN Rapid; IR spectra: Perkin-Elmer FT-IR Paragon 1000; MS: Hewlett Packard MS-Engine, electron ionization (EI) 70 eV, chemical ionization (CI) with CH 4 (300 eV); GLC-MS: Shimadzu GC 17 A, EI (70 eV); NMR: Jeol GSX 400 ( 1 H: 400 MHz, 13 C: 100 MHz); melting points were determined on a Büchi melting point B-540 apparatus and are uncorrected; flash column chromatography (FCC): silica gel 60 (230 -400 mesh, E. Merck, Darmstadt); HPLC: Merck Hitachi Series 7000, column: LiChroCart R 250-4; LiChrospher 100 RP 18 (5µ M, Merck), eluent: methanol / water 75 : 25 (compound 2a and 3a: 90 : 10), detection: UV, λ = 254 nm.
General procedure 1 (Sonogashira reaction)
Pd(PPh 3 ) 2 Cl 2 (0.10 mmol) and ZnCl 2 (4.0 mmol) were added under N 2 atmosphere to a solution of aryl iodide (2.00 mmol), alkyne (6.0 mmol), and triethylamine (10 mmol) in DMF (2 mL). The suspension was heated at 100 • C for 24 h. The components of the suspension were separated by flash column chromatography (n-hexane / ethyl acetate).
General procedure 2 (catalytic hydrogenation)
20 mg of Pd on charcoal (10 %) was added to a solution of the isocoumarin in methanol (20 mL). The suspension was stirred for 12 h under H 2 atmosphere, then the catalyst was filtered off, and the residue was washed with methanol. The combined organic layers were evaporated, and the residue was purified by FCC (n-hexane / ethyl acetate).
3-Dodecylisochromen-1-one (2a)
Compound 2a was prepared following general procedure 1 from 2-iodobenzoic acid (496 mg, 2.00 mmol), tetradec 
3-(9-Hydroxynonyl)-isochromen-1-one (2b)
The compound was prepared following general procedure 1 from 2-iodobenzoic acid (496 mg, 2.00 mmol), undec-10- yn-1-ol (1.0 g, 6.0 mmol), triethylamine (1.0 g, 10 
3-(3-Methylbutyl)isochromen-1-one (2c)
a) The compound was prepared following general procedure 1 from 2-iodobenzoic acid (496 mg, 2.00 mmol), 5-methylhex-1-yne (577 mg, 6.00 mmol), triethylamine ( C-10), 125.01 (C-6), 127.52 (C-8), 129.49 (C-9) 
2-[4-(1-Oxo-1H-isochromen-3-yl)-butyl]isoindol-1,3-dione (2e)
The compound was prepared following general procedure 1 from 2-iodobenzoic acid (496 mg, 2.00 mmol), N-(hex-5- 
(±)-3-(3-Methylbutyl)-isochroman-1-one (3c)
The compound was prepared following general procedure
